Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2

INTRODUCTION: The availability of mice transgenic for the human HER2 gene (huHER2) and prone to the development of HER2-driven mammary carcinogenesis (referred to as FVB-huHER2 mice) prompted us to study active immunopreventive strategies targeting the human HER2 molecule in a tolerant host. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: De Giovanni, Carla, Nicoletti, Giordano, Quaglino, Elena, Landuzzi, Lorena, Palladini, Arianna, Ianzano, Marianna Lucia, Dall’Ora, Massimiliano, Grosso, Valentina, Ranieri, Dario, Laranga, Roberta, Croci, Stefania, Amici, Augusto, Penichet, Manuel L, Iezzi, Manuela, Cavallo, Federica, Nanni, Patrizia, Lollini, Pier-Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979148/
https://www.ncbi.nlm.nih.gov/pubmed/24451168
http://dx.doi.org/10.1186/bcr3602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979148/
https://www.ncbi.nlm.nih.gov/pubmed/24451168
http://dx.doi.org/10.1186/bcr3602

Ejemplares similares